Aquestive Therapeutics, Inc. — Director's Dealing 2019

Mar 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2019-02-28

Reporting Person: Kendall Keith J (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-28	Non-Qualified Stock Option (right to buy)	$8.05	A	325000	Acquired	2029-02-28	Common Stock (325000)	Direct

Footnotes

F1: The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries.